p-11

Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic.

P11 是一种具有选择性的血小板活化因子乙酰水解酶 ( PAFAH1b2 和 PAFAH1b3 ) 抑制剂，阻断 PAFAH1b2 和 PAFAH1b3 介导的底物 PAF 水解为溶血 PAF，可用于研究 PAFAH1b2 3 的细胞功能。

Oligopeptide P11-4 acetate(593266-60-5 free base) 是一种肽。

P11 acetate 是一种整合素 αvβ3-玻连蛋白相互作用拮抗剂 (IC50 = 2.74 nM)。

Piromelatine 是褪黑激素 MT1 MT2 受体、5-HT1A 和 5-HT1D 的激动剂，也是 5-HT2B 的拮抗剂。Piromelatine 具有抗痛觉活性，对 P2X3、TRPV1 和 Nav1.7 通道有抑制作用，可用于促进睡眠、缓解疼痛、抗神经退行性疾病和抗抑郁疾病的研究。

P-113 acetate 是一种源自人类唾液蛋白组氨酸 5 的抗菌肽 (AMP)，在患有口腔念珠菌病的牙龈炎和人类免疫缺陷病毒 (HIV) 患者中显示出良好的安全性和有效性。

CEP-11981 (ESK981 ; BOL 303213X) 是一种具有口服活性的酪氨酸激酶抑制剂(TKI)，可以靶向 TIE2，VEGFR1-3和FGFR1，具有潜在的抗肿瘤和抗血管生成效果。

4-Fluorophenibut (developmental code name CGP-11130; also known as β-(4-fluorophenyl)-γ-aminobutyric acid or β-(4-fluorophenyl)-GABA) is a GABAB receptor agonist which was never marketed. It is selective for the GABAB receptor over the GABAA receptor (IC50 = 1.70 μM and > 100 μM, respectively). The drug is a GABA analogue and is closely related to baclofen (β-(4-chlorophenyl)-GABA), tolibut (β-(4-methylphenyl)-GABA), and phenibut (β-phenyl-GABA). It is less potent as a GABAB receptor agonist than baclofen but more potent than phenibut.

JTP-117968 是一种选择性的糖皮质激素受体调节剂 (非甾类的 SGRM，IC50值为 6.8 nM)，表现出改善的转录抑制 转激活解离效果。

NEPP-11 is a selective JNK signaling pathway inhibitor.

CP-113818 是一种胆固醇酰基转移酶 (ACAT) 的有效抑制剂，能够用于研究阿尔茨海默病。

CPP-115 is a GABA-aminotransferase inhibitor and a high-affinity vigabatrin analogue.

P-113 is a peptide with antimicrobial activity.

TP-110 is a new proteasome inhibitor, which shows potent growth inhibition in various tumor cell lines. Treatment with TP-110 for 24 h in vitro induced apoptosis in multiple myeloma cell line RPMI8226. TP-110 reduced the intrinsic inhibitor of apoptosis proteins (IAPs), cIAP-1 and XIAP, that suppress executioner caspases.

HSP-117 free base is a novel tachykinin NK1-receptor antagonist.

AKP-11 is a sphingosine-1-phosphate receptor 1 (S1P1) agonist with an EC50 of 0.047 μM for [35S]GTPγS binding to CHO-K1 cell membranes expressing human S1P1. It reduces S1P1 surface expression and enhances Akt and ERK phosphorylation in CHO cells with S1P1-HA at a 100 nM concentration. At doses of 1.3 and 3 mg kg, AKP-11 lowers IFN-γ and IL-17 protein levels in the spinal cord and mitigates disease severity in a rat experimental autoimmune encephalomyelitis (EAE) model. Additionally, it decreases peripheral total lymphocyte and specific T cell subsets (CD4+, CD8+, and CD26L+ T cells) counts in both EAE rats and healthy controls at a 1.3 mg kg dosage.

CEP-11981 (tosylate) (ESK981 (tosylate), BOL 303213X (tosylate)) 为一种口服活性的酪氨酸激酶抑制剂 (TKI)，能靶向 TIE2，VEGFR1-3 和 FGFR1，展现出潜在的抗肿瘤及抗血管生成效果。

CP-114271 is a bio-active chemical.

HSP-117 dihydrochloride is a novel tachykinin NK1-receptor antagonist.

P-113D，作为一种对抗铜绿假单胞菌有着显著效果的抗菌肽，显示出优异的抗菌活性, 在囊性纤维化研究中应用广泛。其对ATCC 27853的最小抑菌浓度 (MIC) 为3.1 μg mL。

LY294002 (SF 1101) 是一种 PI3K 的广谱抑制剂，抑制 PI3Kα、PI3Kδ 和 PI3Kβ (IC50=0.5 0.57 0.97 μM)。LY294002 也是 DNA-PK 抑制剂 (IC50=1.4 μM) 和 CK2 抑制剂 (IC50=98 nM)。LY294002 可以激活凋亡和自噬。

Torin 1 是一种 mTOR 抑制剂，可以抑制 mTORC1 和 mTORC2 (IC50=2 10 nM)，具有选择性和 ATP 竞争性。Torin 1 可以诱导细胞自噬，具有抗肿瘤、抗炎、抗衰老活性。

RMP1-14 是一种 IgG 样免疫球蛋白抗小鼠 PD-1 抗体，可阻断 PD-1 PD-L1 信号传导；其同型对照抗体为Mouse IgG2a kappa, Isotype Control。

Alpelisib (BYL-719) 是一种 PI3Kα 抑制剂 (IC50=5 nM)，具有选择性、有效性和口服活性。Alpelisib 以较低活性抑制 PI3Kβ γ δ (IC50=250 290 1200 nM)。Alpelisib 具有抗肿瘤活性，对 PIK3CA 突变肿瘤具有靶向性。